The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“In solid cancers, two major types of genetic instability have been described, based on the findings initially observed in colorectal cancer (Lengauer et al., 1998).”
BackgroundHartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · cited 2×
“Moreover, HDAC6, another tubulin deacetylase (Hubbert et al., 2002), increases cell motility (Saji et al., 2005) and inhibits the clustering of CD3 in the central region of the immune synapse and of LFA-1 in the periphery by decreasing the acetylation of microtubules at contact regions (Serrador et…”
BackgroundThe Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., & Verdin, E. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00038-8 · Cited by 1,536
Nucleocytoplasmic transport: the soluble phase
Mattaj, I. W., & Englmeier, L. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.265 · Cited by 1,175
Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, B., Yoshida, M., & Horinouchi, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9112 · Cited by 1,029
Cleveland, D. W., Mao, Y., & Sullivan, K. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00115-6 · Cited by 1,003
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873 · cited 1×
“Acetylated tubulin is abundant in stable microtubules but it is absent from dynamic cellular structure such as the leading edges of fibroblast (Piperno et al., 1987).”
BackgroundAnalysis and prediction of leucine-rich nuclear export signals
la Cour, T., Kiemer, L., Mølgaard, A., Gupta, R., Skriver, K., & Brunak, S. (2004) · Protein Engineering, Design and Selection · doi:10.1093/protein/gzh062 · Cited by 759
Paulovich, A. G., Toczyski, D. P., & Hartwell, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)81870-x · Cited by 616
The spindle checkpoint: structural insights into dynamic signalling
Musacchio, A., & Hardwick, K. G. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm929 · Cited by 531
Role for Human SIRT2 NAD-Dependent Deacetylase Activity in Control of Mitotic Exit in the Cell Cycle
Dryden, S. C., Nahhas, F. A., Nowak, J. E., Goustin, A.-S., & Tainsky, M. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3173-3185.2003 · Cited by 498
Structure of the histone deacetylase SIRT2.
Finnin, M. S., Donigian, J. R., & Pavletich, N. P. (2001) · Nature Structural Biology · doi:10.1038/89668 · Cited by 435
Amon, A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80010-0 · Cited by 395
Polo-like kinases (Plks) and cancer
Takai, N., Hamanaka, R., Yoshimatsu, J., & Miyakawa, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208272 · Cited by 386
Chfr defines a mitotic stress checkpoint that delays entry into metaphase
Scolnick, D. M., & Halazonetis, T. D. (2000) · Nature · doi:10.1038/35019108 · Cited by 375
Hiratsuka, M., Inoue, T., Toda, T., Kimura, N., Shirayoshi, Y., Kamitani, H., Watanabe, T., Ohama, E., Tahimic, C. G. T., Kurimasa, A., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.029 · Cited by 260
Self-citationSaji, S., Kawakami, M., Hayashi, S.-I., Yoshida, N., Hirose, M., Horiguchi, S.-I., Itoh, A., Funata, N., Schreiber, S. L., Yoshida, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208646 · Cited by 258
Model for the genetic evolution of human solid tumors.
Shackney, S. E., Smith, C., Miller, B. W., Burholt, D. R., Murtha, K., Giles, H. R., Ketterer, D. M., & Pollice, A. A. (1989) · PubMed · Cited by 252
Leonardo, A. D., Khan, S. H., Linke, S. P., Greco, V., Seidita, G., & Wahl, G. M. (1997) · PubMed · Cited by 198
Chfr is required for tumor suppression and Aurora A regulation
Yu, X., Minter-Dykhouse, K., Malureanu, L., Zhao, W.-M., Zhang, D., Merkle, C. J., Ward, I. M., Saya, H., Fang, G., van Deursen, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1538 · Cited by 197
HDAC6 Deacetylase Activity Links the Tubulin Cytoskeleton with Immune Synapse Organization
Serrador, J. M., Cabrero, J. R., Sancho, D., Mittelbrunn, M., Urzainqui, A., & Sánchez-Madrid, F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00078-0 · Cited by 193
Kang, D., Chen, J., Wong, J., & Fang, G. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108016 · Cited by 191
Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma
Bigner, S. H., & Vogelstein, B. (1990) · Brain Pathology · doi:10.1111/j.1750-3639.1990.tb00633.x · Cited by 158
A cytokinesis checkpoint requiring the yeast homologue of an APC-binding protein
Muhua, L., Adames, N. R., Murphy, M. D., Shields, C. R., & Cooper, J. A. (1998) · Nature · doi:10.1038/31014 · Cited by 153
Id Helix-Loop-Helix Proteins Antagonize Pax Transcription Factor Activity by Inhibiting DNA Binding
Roberts, E. C., Deed, R. W., Inoue, T., Norton, J. D., & Sharrocks, A. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.524-533.2001 · Cited by 139
Self-citationAberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
Mizuno, K., Osada, H., Konishi, H., Tatematsu, Y., Yatabe, Y., Mitsudomi, T., Fujii, Y., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205402 · Cited by 125
Chemopreventive Strategies Using NSAIDs and COX-2 Inhibitors
Keller, J. J., & Giardello, F. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.214 · Cited by 125
Proteomic identification of differentially‐expressed genes in human gastric carcinomas
Nishigaki, R., Osaki, M., Hiratsuka, M., Toda, T., Murakami, K., Jeang, K., Ito, H., Inoue, T., & Oshimura, M. (2005) · PROTEOMICS · doi:10.1002/pmic.200401307 · Cited by 122
Self-citationTakahashi, T., Shivapurkar, N., Riquelme, E. M., Shigematsu, H., Reddy, J., Suzuki, M., Miyajima, K., Zhou, X. C., Bekele, B. N., Gazdar, A. F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0579 · Cited by 110
Regulation of cell cycle checkpoints by polo-like kinases
Xie, S., Xie, B., Lee, M. Y., & Dai, W. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208218 · Cited by 106
Imai, Y., Shiratori, Y., Kato, N., Inoue, T., & Omata, M. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00824.x · Cited by 98
Self-citationHuman Histone Deacetylase SIRT2 Interacts with the Homeobox Transcription Factor HOXA10
Bae, N. S., Swanson, M. J., Vassilev, A., & Howard, B. H. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh084 · Cited by 93
Brandes, J. C., van Engeland, M., Wouters, K. A. D., Weijenberg, M. P., & Herman, J. G. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi058 · Cited by 92
Alonso, M., Tamasdan, C., Miller, D. C., & Newcomb, E. W. (2003) · PubMed · Cited by 87
Kyrylenko, S., Kyrylenko, O., Suuronen, T., & Salminen, A. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3090-z · Cited by 81
Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines
Tsuiki, H., Nitta, M., Tada, M., Inagaki, M., Ushio, Y., & Saya, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204126 · Cited by 53
Qian, K. X., Chen, H., Wei, Y.-L., Hu, J., & Zhu, G. (2005) · Molecular Human Reproduction · doi:10.1093/molehr/gah147 · Cited by 36
Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability
Nitta, M., Tsuiki, H., Arima, Y., Harada, K., Nishizaki, T., Sasaki, K., Mimori, T., Ushio, Y., & Saya, H. (2002) · Genes to Cells · doi:10.1046/j.1356-9597.2001.00509.x · Cited by 25
Cited by
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
Sirtuins in mammals: insights into their biological function
Michan, S., & Sinclair, D. (2007) · Biochemical Journal · doi:10.1042/bj20070140 · Cited by 1,718
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
“Furthermore, SIRT2 acts as a mitotic checkpoint that prevents chromosomal instability and the formation of hyperploid cells in the early metaphase (115).”
BackgroundEpigenetics and aging: the targets and the marks
Fraga, M. F., & Esteller, M. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.05.008 · Cited by 690
SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
Kim, H.-S., Vassilopoulos, A., Wang, R.-H., Lahusen, T., Xiao, Z., Xu, X., Li, C., Veenstra, T. D., Li, B., Yu, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.004 · Cited by 537
Metadata
- Authors
- Inoue, T., Hiratsuka, M., Osaki, M., Yamada, H., Kishimoto, I., Yamaguchi, S., Nakano, S., Katoh, M., Ito, H., & Oshimura, M.
- Venue
- Oncogene
- Published
- 2006-08-14
- Volume
- 26
- Issue
- 7
- Pages
- 945-957
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2046232891
- Cited by
- 258
- References
- 39
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.